Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells

por Yamashita, Ryo, Sato, Mitsuo, Kakumu, Tomohiko, Hase, Tetsunari, Yogo, Naoyuki, Maruyama, Eiichi, Sekido, Yoshitaka, Kondo, Masashi, Hasegawa, Yoshinori
Publicado 2015

Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer

por Kakumu, Tomohiko, Sato, Mitsuo, Goto, Daiki, Kato, Toshio, Yogo, Naoyuki, Hase, Tetsunari, Morise, Masahiro, Fukui, Takayuki, Yokoi, Kohei, Sekido, Yoshitaka, Girard, Luc, Minna, John D., Byers, Lauren A., Heymach, John V., Coombes, Kevin R., Kondo, Masashi, Hasegawa, Yoshinori
Publicado 2017

eIF2β, a subunit of translation‐initiation factor EIF2, is a potential therapeutic target for non‐small cell lung cancer

por Tanaka, Ichidai, Sato, Mitsuo, Kato, Toshio, Goto, Daiki, Kakumu, Tomohiko, Miyazawa, Ayako, Yogo, Naoyuki, Hase, Tetsunari, Morise, Masahiro, Sekido, Yoshitaka, Girard, Luc, Minna, John D., Byers, Lauren A., Heymach, John V., Coombes, Kevin R., Kondo, Masashi, Hasegawa, Yoshinori
Publicado 2018